SCHEMBL5389142

SCHEMBL5389142

COc1ccc(N2CCC3(CCNC3)C2)cn1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 4/20 0.57
CHRNA4 P43681 4/20 0.57
ALDH1A1 P00352 5/20 0.47
CYP1A2 P05177 4/20 0.47
CYP2D6 P10635 4/20 0.47
CYP3A4 P08684 4/20 0.47
USP2 O75604 3/20 0.47
HSD17B10 Q99714 4/20 0.46
HPGD P15428 2/20 0.46
TP53 P04637 2/20 0.46
MAPK1 P28482 2/20 0.46
CYP2C19 P33261 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CHRNB4 P30926 3/20 0.44
CHRNA3 P32297 3/20 0.44
KHK P50053 1/20 0.44
TSHR P16473 1/20 0.43
KCNJ1 P48048 1/20 0.43
KCNH2 Q12809 1/20 0.43
NTRK1 P04629 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20468858 0.83 ALDH1A1 (0.50) CHRNB2CHRNA4ALDH1A1CYP1A2CYP2D6
SCHEMBL20798113 0.83 CHRNB2 (0.56) CHRNB2CHRNA4CHRNB4CHRNA3KCNJ1
SCHEMBL30057551 0.83 CHRNB2 (0.56) CHRNB2CHRNA4CHRNB4CHRNA3KCNJ1
SCHEMBL20469182 0.81 ALDH1A1 (0.46) ALDH1A1CYP1A2CYP2D6CYP3A4USP2
SCHEMBL1556835 0.81 CHRNB4 (0.61) CHRNB2CHRNA4ALDH1A1CYP1A2CYP2D6
SCHEMBL1426895 0.81 ALDH1A1 (0.50) CHRNB2CHRNA4ALDH1A1CYP1A2CYP2D6
SCHEMBL1426554 0.80 USP2 (0.56) ALDH1A1CYP1A2CYP2D6CYP3A4USP2
SCHEMBL1556717 0.80 ALDH1A1 (0.47) ALDH1A1CYP1A2CYP2D6CYP3A4USP2
SCHEMBL20468861 0.79 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2D6CYP3A4USP2
SCHEMBL1556724 0.79 CHRNB2 (0.61) CHRNB2CHRNA4ALDH1A1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7291731-B2 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof TARGACEPT, INC. (US) 2007-11-06 US disclosed
US-20050272739-A1 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof BHATTI BALWINDER S 2005-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272739-A1 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof TNNC1, ACHE, CHRNA6 CHRNB2 14/4885CHRNA4 9/4885ALDH1A1 1337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.